Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Cyclopenthiazide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 7/20 | 0.76 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.76 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.76 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.71 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.71 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
| ▸ | ATM | Q13315 | 1/20 | 0.48 |
| ▸ | CA2 | P00918 | 3/20 | 0.46 |
| ▸ | CA7 | P43166 | 2/20 | 0.46 |
| ▸ | CA1 | P00915 | 2/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | CA12 | O43570 | 1/20 | 0.46 |
| ▸ | CA4 | P22748 | 1/20 | 0.46 |
| ▸ | CA6 | P23280 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cyclopenthiazide SCHEMBL28832656 | 1.00 | LMNA (0.76) | LMNACYP2C9ADRA2BCHRM1ADRA1A | |
| Cyclopenthiazide SCHEMBL49142 | 0.87 | LMNA (1.00) | LMNACYP2C9ADRA2BCHRM1ADRA1A | |
| Cyclopenthiazide SCHEMBL30561852 | 0.87 | LMNA (1.00) | LMNACYP2C9ADRA2BCHRM1ADRA1A | |
| SCHEMBL30561876 | 0.86 | LMNA (0.98) | LMNACYP2C9ADRA2BCHRM1ADRA1A | |
| SCHEMBL29132641 | 0.86 | LMNA (0.98) | LMNACYP2C9ADRA2BCHRM1ADRA1A | |
| Cyclopenthiazide SCHEMBL9505656 | 0.85 | LMNA (0.96) | LMNACYP2C9ADRA2BCHRM1ADRA1A | |
| Methyclothiazide SCHEMBL8051136 | 0.84 | CHRM1 (1.00) | LMNACYP2C9ADRA2BCHRM1ADRA1A | |
| Methyclothiazide SCHEMBL49396 | 0.84 | CHRM1 (1.00) | LMNACYP2C9ADRA2BCHRM1ADRA1A | |
| Methyclothiazide SCHEMBL1819665 | 0.84 | CHRM1 (1.00) | LMNACYP2C9ADRA2BCHRM1ADRA1A | |
| Methyclothiazide SCHEMBL27178 | 0.84 | CHRM1 (1.00) | LMNACYP2C9ADRA2BCHRM1ADRA1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103717597-B | Heterocyclic compounds as kinase inhibitors | 原真股份有限公司 | 2017-07-04 | — | — | CN | disclosed |